Introduction and Overview — Addressing Current Challenges in Thrombosis Medicine for the CV Specialist Samuel Z. Goldhaber, MD
The Emerging Role of Direct Thrombin and Factor Xa Inhibition in Cardiovascular Medicine: Mechanisms and Applications for Thrombosis Mitigation Across the CV Disease Spectrum Jeffrey L. Weitz, MD, FRCP, FACP
Challenges and Emerging Dimensions of Stroke Prevention in the Setting of Atrial Fibrillation (AF): Achieving Balance Between Thromboprophylaxis and Bleeding Reduction Jonathan L. Halperin, MD
Stroke Prevention in High Risk Populations: From Warfarin to New Options and Strategies Elaine M. Hylek, MD, MPH
Anticoagulation for Stroke Prevention in Atrial Fibrillation Samuel Z. Goldhaber, MD
Question and Answer Interactive Session Faculty Panel